Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BRISTOL MYERS SQUIBB COBMY · Entity 1662 | SVP, Head of Strategy & BD | October 02, 2019 | October 03, 2019 |
| Seres Therapeutics, Inc.MCRB · Entity 7191 | Director | April 10, 2025 | April 11, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BRISTOL MYERS SQUIBB CO
Report date October 02, 2019 · Filed October 03, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.10 par valueSEC Table I · non-derivative | Direct | 6,214 |
Ending reported balance
After 2019-10-02 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2019-10-02 · Exercise / conversion · Acquired 592 · Balance 6,417 F1: Represents vesting of one quarter of restricted stock units granted on October 2, 2017. The balance of the award is scheduled to vest in two equal installments on the third and fourth anniversaries of the grant date. Row 2 · 2019-10-02 · Tax withholding · Disposed 203 · Balance 6,214 F2: Shares withheld for payment of taxes upon vesting of awards. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Expires 2021-10-02 | Direct | 1,184 |
Reported balance
After 2019-10-02 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2019-10-02 · Exercise / conversion · Disposed 592 · Balance 1,184 F3: Each restricted stock unit converts into one share of common stock upon vesting. F1: Represents vesting of one quarter of restricted stock units granted on October 2, 2017. The balance of the award is scheduled to vest in two equal installments on the third and fourth anniversaries of the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents vesting of one quarter of restricted stock units granted on October 2, 2017. The balance of the award is scheduled to vest in two equal installments on the third and fourth anniversaries of the grant date.
F2: Shares withheld for payment of taxes upon vesting of awards.
F3: Each restricted stock unit converts into one share of common stock upon vesting.
Seres Therapeutics, Inc.
Report date April 10, 2025 · Filed April 11, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.58 · Expires 2035-04-09 | Direct | 100,000 |
Reported balance
After 2025-04-10 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-04-10 · Grant · Acquired 100,000 · Balance 100,000 F1: The option vests in full on the earlier of April 10, 2026 or the day immediately prior to the company's 2026 annual meeting of shareholders. |
Filing footnotes · ownership attribution and instrument terms
F1: The option vests in full on the earlier of April 10, 2026 or the day immediately prior to the company's 2026 annual meeting of shareholders.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 10, 2025 Filed Apr 11, 2025 20:05 UTC | Seres Therapeutics, Inc. MCRB · Entity 7191 | GrantStock Option (right to buy) · Derivative | 100,000 | $0.00 Strike: $0.58 | $0.00 |
DisclosureSEC source: 0000950170-25-053250 · ownership.xml · derivative · entry 1 Biondi Paul · CIK 0001744508 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2035-04-09 F1 · derivative.exercise_date: The option vests in full on the earlier of April 10, 2026 or the day immediately prior to the company's 2026 annual meeting of shareholders. Read SEC document |
| April 04, 2024 Filed Apr 8, 2024 20:45 UTC | Seres Therapeutics, Inc. MCRB · Entity 7191 | GrantStock Option (Right to Buy) · Derivative | 60,000 | $0.00 Strike: $0.76 | $0.00 |
DisclosureSEC source: 0000950170-24-042657 · ownership.xml · derivative · entry 1 Biondi Paul · CIK 0001744508 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2034-04-03 F1 · derivative.exercise_date: The option vests in full on the earlier of April 4, 2025 or the day immediately prior to the company's 2025 annual meeting of shareholders. Read SEC document |
| June 22, 2023 Filed Jun 23, 2023 21:35 UTC | Seres Therapeutics, Inc. MCRB · Entity 7191 | GrantStock Option (right to buy) · Derivative | 35,000 | $0.00 Strike: $5.46 | $0.00 |
DisclosureSEC source: 0000899243-23-016412 · doc4.xml · derivative · entry 1 Biondi Paul · CIK 0001744508 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2033-06-21 F1 · derivative.exercise_date: The option vests in full on the earlier of June 22, 2024 or the day immediately prior to the company's 2024 annual meeting of shareholders. Read SEC document |
| July 05, 2022 Filed Jul 6, 2022 23:19 UTC | Seres Therapeutics, Inc. MCRB · Entity 7191 | GrantCOMMON STOCK | 47,619 | $3.15 | $149,999.85 |
DisclosureSEC source: 0000899243-22-025505 · doc4.xml · nonDerivative · entry 1 Biondi Paul · CIK 0001744508 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,619 Read SEC document |
| June 22, 2022 Filed Jun 24, 2022 20:35 UTC | Seres Therapeutics, Inc. MCRB · Entity 7191 | GrantStock Option (right to buy) · Derivative | 35,000 | $0.00 Strike: $3.22 | $0.00 |
DisclosureSEC source: 0000899243-22-024004 · doc4.xml · derivative · entry 1 Biondi Paul · CIK 0001744508 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2032-06-21 F1 · derivative.exercise_date: The option vests in full on the earlier of June 22, 2023 or the day immediately prior to the company's 2023 annual meeting of shareholders. Read SEC document |
| June 16, 2021 Filed Jun 21, 2021 20:31 UTC | Seres Therapeutics, Inc. MCRB · Entity 7191 | GrantStock Option (right to buy) · Derivative | 23,000 | $0.00 Strike: $19.74 | $0.00 |
DisclosureSEC source: 0000899243-21-025000 · doc4.xml · derivative · entry 1 Biondi Paul · CIK 0001744508 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,000 Underlying: Common Stock · 23,000 shares Expires 2031-06-15 F1 · derivative.exercise_date: The option vests in full on the earlier of June 16, 2022 or the day immediately prior to the company's 2022 annual meeting of shareholders. Read SEC document |
| June 18, 2020 Filed Jun 22, 2020 20:18 UTC | Seres Therapeutics, Inc. MCRB · Entity 7191 | GrantStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $4.40 | $0.00 |
DisclosureSEC source: 0000899243-20-017363 · doc4.xml · derivative · entry 1 Biondi Paul · CIK 0001744508 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2030-06-17 F1 · derivative.exercise_date: The option vests in full on the earlier of June 18, 2021 or the day immediately prior to the company's 2021 annual meeting of shareholders. Read SEC document |
| March 20, 2020 Filed Mar 23, 2020 20:11 UTC | Seres Therapeutics, Inc. MCRB · Entity 7191 | GrantStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $3.10 | $0.00 |
DisclosureSEC source: 0000899243-20-009250 · doc4.xml · derivative · entry 1 Biondi Paul · CIK 0001744508 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2030-03-19 F1 · derivative.exercise_date: The option will vest in four equal installments on each anniversary of March 20, 2020 or in full immediately prior to the occurrence of a change in control. Read SEC document |
| October 02, 2019 Filed Oct 3, 2019 20:46 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionRestricted Stock Units · Derivative | 592 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-19-000184 · wf-form4_157013557942143.xml · derivative · entry 3 Biondi Paul · CIK 0001744508 · SVP, Head of Strategy & BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,184 Underlying: Common Stock, $0.10 par value · 592 shares Expires 2021-10-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting. F1 · shares: Represents vesting of one quarter of restricted stock units granted on October 2, 2017. The balance of the award is scheduled to vest in two equal installments on the third and fourth anniversaries of the grant date. F1 · derivative.exercise_date: Represents vesting of one quarter of restricted stock units granted on October 2, 2017. The balance of the award is scheduled to vest in two equal installments on the third and fourth anniversaries of the grant date. F1 · derivative.expiration_date: Represents vesting of one quarter of restricted stock units granted on October 2, 2017. The balance of the award is scheduled to vest in two equal installments on the third and fourth anniversaries of the grant date. Read SEC document |
| October 02, 2019 Filed Oct 3, 2019 20:46 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 203 | $49.21 | $9,989.63 |
DisclosureSEC source: 0000014272-19-000184 · wf-form4_157013557942143.xml · nonDerivative · entry 2 Biondi Paul · CIK 0001744508 · SVP, Head of Strategy & BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,214 F2 · shares: Shares withheld for payment of taxes upon vesting of awards. Read SEC document |
| October 02, 2019 Filed Oct 3, 2019 20:46 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionCommon Stock, $0.10 par value | 592 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-19-000184 · wf-form4_157013557942143.xml · nonDerivative · entry 1 Biondi Paul · CIK 0001744508 · SVP, Head of Strategy & BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,417 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents vesting of one quarter of restricted stock units granted on October 2, 2017. The balance of the award is scheduled to vest in two equal installments on the third and fourth anniversaries of the grant date. Read SEC document |
| March 10, 2019 Filed Mar 13, 2019 11:39 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantPerformance Shares · Derivative | 11,641 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-19-000078 · wf-form4_155247717979828.xml · derivative · entry 21 Biondi Paul · CIK 0001744508 · SVP, Head of Strategy & BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,641 Underlying: Common Stock, $0.10 par value · 11,641 shares Expires 2022-03-10 F11 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2022. F11 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2022. Read SEC document |
| March 10, 2019 Filed Mar 13, 2019 11:39 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionPerformance Shares · Derivative | 5,093 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-19-000078 · wf-form4_155247717979828.xml · derivative · entry 20 Biondi Paul · CIK 0001744508 · SVP, Head of Strategy & BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 5,093 shares Expires 2019-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2019, subject to a Total Shareholder Return modifier. F7 · shares: Amount represents distribution of performance shares earned under the 2016-2018 Long-Term Performance Award based on the performance factor applied in accordance with the terms of the Award and certification of performance results by the Board. F10 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2019, subject to a Total Shareholder Return modifier. Read SEC document |
| March 10, 2019 Filed Mar 13, 2019 11:39 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantMarket Share Units · Derivative | 7,760 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-19-000078 · wf-form4_155247717979828.xml · derivative · entry 19 Biondi Paul · CIK 0001744508 · SVP, Head of Strategy & BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,760 Underlying: Common Stock, $0.10 par value · 7,760 shares Expires 2023-03-10 F8 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%. F9 · derivative.exercise_date: Twenty-five percent of these market share units will vest on each of the first, second, third, and fourth anniversaries of the grant date. Read SEC document |
| March 10, 2019 Filed Mar 13, 2019 11:39 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionMarket Share Units · Derivative | 926 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-19-000078 · wf-form4_155247717979828.xml · derivative · entry 18 Biondi Paul · CIK 0001744508 · SVP, Head of Strategy & BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,781 Underlying: Common Stock, $0.10 par value · 926 shares Expires 2022-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%. F6 · derivative.exercise_date: Represents vesting of one-quarter of market share units granted on March 10, 2018. Read SEC document |
| March 10, 2019 Filed Mar 13, 2019 11:39 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionMarket Share Units · Derivative | 1,095 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-19-000078 · wf-form4_155247717979828.xml · derivative · entry 17 Biondi Paul · CIK 0001744508 · SVP, Head of Strategy & BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,191 Underlying: Common Stock, $0.10 par value · 1,095 shares Expires 2021-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%. F5 · derivative.exercise_date: Represents vesting of one-quarter of market share units granted on March 10, 2017. Read SEC document |
| March 10, 2019 Filed Mar 13, 2019 11:39 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionMarket Share Units · Derivative | 857 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-19-000078 · wf-form4_155247717979828.xml · derivative · entry 16 Biondi Paul · CIK 0001744508 · SVP, Head of Strategy & BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 859 Underlying: Common Stock, $0.10 par value · 857 shares Expires 2020-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%. F4 · derivative.exercise_date: Represents vesting of one-quarter of market share units granted on March 10, 2016. Read SEC document |
| March 10, 2019 Filed Mar 13, 2019 11:39 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionMarket Share Units · Derivative | 648 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-19-000078 · wf-form4_155247717979828.xml · derivative · entry 15 Biondi Paul · CIK 0001744508 · SVP, Head of Strategy & BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 648 shares Expires 2019-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%. F1 · derivative.exercise_date: Represents vesting of one-quarter of market share units granted on March 10, 2015. Read SEC document |
| March 10, 2019 Filed Mar 13, 2019 11:39 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 2,035 | $51.39 | $104,578.65 |
DisclosureSEC source: 0000014272-19-000078 · wf-form4_155247717979828.xml · nonDerivative · entry 14 Biondi Paul · CIK 0001744508 · SVP, Head of Strategy & BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,825 F3 · shares: Shares withheld for payment of taxes upon vesting of awards. Read SEC document |
| March 10, 2019 Filed Mar 13, 2019 11:39 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionCommon Stock, $0.10 par value | 5,093 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-19-000078 · wf-form4_155247717979828.xml · nonDerivative · entry 13 Biondi Paul · CIK 0001744508 · SVP, Head of Strategy & BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,860 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · shares: Amount represents distribution of performance shares earned under the 2016-2018 Long-Term Performance Award based on the performance factor applied in accordance with the terms of the Award and certification of performance results by the Board. Read SEC document |
| March 10, 2019 Filed Mar 13, 2019 11:39 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 283 | $51.39 | $14,543.37 |
DisclosureSEC source: 0000014272-19-000078 · wf-form4_155247717979828.xml · nonDerivative · entry 12 Biondi Paul · CIK 0001744508 · SVP, Head of Strategy & BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,767 F3 · shares: Shares withheld for payment of taxes upon vesting of awards. Read SEC document |
| March 10, 2019 Filed Mar 13, 2019 11:39 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | OtherCommon Stock, $0.10 par value | 219 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-19-000078 · wf-form4_155247717979828.xml · nonDerivative · entry 11 Biondi Paul · CIK 0001744508 · SVP, Head of Strategy & BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,050 F2 · shares: Represents a downward adjustment to the number of shares acquired upon the vesting of market share units due to the performance factor. Read SEC document |
| March 10, 2019 Filed Mar 13, 2019 11:39 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionCommon Stock, $0.10 par value | 926 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-19-000078 · wf-form4_155247717979828.xml · nonDerivative · entry 10 Biondi Paul · CIK 0001744508 · SVP, Head of Strategy & BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,269 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · shares: Represents vesting of one-quarter of market share units granted on March 10, 2018. Read SEC document |
| March 10, 2019 Filed Mar 13, 2019 11:39 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 391 | $51.39 | $20,093.49 |
DisclosureSEC source: 0000014272-19-000078 · wf-form4_155247717979828.xml · nonDerivative · entry 9 Biondi Paul · CIK 0001744508 · SVP, Head of Strategy & BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,343 F3 · shares: Shares withheld for payment of taxes upon vesting of awards. Read SEC document |
| March 10, 2019 Filed Mar 13, 2019 11:39 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | OtherCommon Stock, $0.10 par value | 118 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-19-000078 · wf-form4_155247717979828.xml · nonDerivative · entry 8 Biondi Paul · CIK 0001744508 · SVP, Head of Strategy & BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,734 F2 · shares: Represents a downward adjustment to the number of shares acquired upon the vesting of market share units due to the performance factor. Read SEC document |
| March 10, 2019 Filed Mar 13, 2019 11:39 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionCommon Stock, $0.10 par value | 1,095 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-19-000078 · wf-form4_155247717979828.xml · nonDerivative · entry 7 Biondi Paul · CIK 0001744508 · SVP, Head of Strategy & BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,852 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · shares: Represents vesting of one-quarter of market share units granted on March 10, 2017. Read SEC document |
| March 10, 2019 Filed Mar 13, 2019 11:39 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 271 | $51.39 | $13,926.69 |
DisclosureSEC source: 0000014272-19-000078 · wf-form4_155247717979828.xml · nonDerivative · entry 6 Biondi Paul · CIK 0001744508 · SVP, Head of Strategy & BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,757 F3 · shares: Shares withheld for payment of taxes upon vesting of awards. Read SEC document |
| March 10, 2019 Filed Mar 13, 2019 11:39 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | OtherCommon Stock, $0.10 par value | 181 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-19-000078 · wf-form4_155247717979828.xml · nonDerivative · entry 5 Biondi Paul · CIK 0001744508 · SVP, Head of Strategy & BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,028 F2 · shares: Represents a downward adjustment to the number of shares acquired upon the vesting of market share units due to the performance factor. Read SEC document |
| March 10, 2019 Filed Mar 13, 2019 11:39 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionCommon Stock, $0.10 par value | 857 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-19-000078 · wf-form4_155247717979828.xml · nonDerivative · entry 4 Biondi Paul · CIK 0001744508 · SVP, Head of Strategy & BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,209 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: Represents vesting of one-quarter of market share units granted on March 10, 2016. Read SEC document |
| March 10, 2019 Filed Mar 13, 2019 11:39 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 208 | $51.39 | $10,689.12 |
DisclosureSEC source: 0000014272-19-000078 · wf-form4_155247717979828.xml · nonDerivative · entry 3 Biondi Paul · CIK 0001744508 · SVP, Head of Strategy & BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,352 F3 · shares: Shares withheld for payment of taxes upon vesting of awards. Read SEC document |
| March 10, 2019 Filed Mar 13, 2019 11:39 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | OtherCommon Stock, $0.10 par value | 129 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-19-000078 · wf-form4_155247717979828.xml · nonDerivative · entry 2 Biondi Paul · CIK 0001744508 · SVP, Head of Strategy & BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,560 F2 · shares: Represents a downward adjustment to the number of shares acquired upon the vesting of market share units due to the performance factor. Read SEC document |
| March 10, 2019 Filed Mar 13, 2019 11:39 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionCommon Stock, $0.10 par value | 648 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-19-000078 · wf-form4_155247717979828.xml · nonDerivative · entry 1 Biondi Paul · CIK 0001744508 · SVP, Head of Strategy & BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,689 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents vesting of one-quarter of market share units granted on March 10, 2015. Read SEC document |
| October 02, 2018 Filed Oct 4, 2018 20:56 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionRestricted Stock Units · Derivative | 592 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-18-000190 · wf-form4_153868655829280.xml · derivative · entry 3 Biondi Paul · CIK 0001744508 · SVP, Head of Strategy & BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,776 Underlying: Common Stock, $0.10 par value · 592 shares Expires 2021-10-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting. F3 · derivative.exercise_date: Represents vesting of one quarter of restricted stock units granted on October 2, 2017. The balance of the award is scheduled to vest in three equal installments on the second, third and fourth anniversaries of the grant date. F3 · derivative.expiration_date: Represents vesting of one quarter of restricted stock units granted on October 2, 2017. The balance of the award is scheduled to vest in three equal installments on the second, third and fourth anniversaries of the grant date. Read SEC document |
| October 02, 2018 Filed Oct 4, 2018 20:56 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 292 | $62.80 | $18,337.60 |
DisclosureSEC source: 0000014272-18-000190 · wf-form4_153868655829280.xml · nonDerivative · entry 2 Biondi Paul · CIK 0001744508 · SVP, Head of Strategy & BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300 F1 · shares: Shares withheld for payment of taxes upon vesting of awards. Read SEC document |
| October 02, 2018 Filed Oct 4, 2018 20:56 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionCommon Stock, $0.10 par value | 592 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-18-000190 · wf-form4_153868655829280.xml · nonDerivative · entry 1 Biondi Paul · CIK 0001744508 · SVP, Head of Strategy & BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 592 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 02, 2018 Filed May 6, 2019 20:39 UTC Amendment | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionRestricted Stock Units · Derivative | 592 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-19-000110 · wf-form4a_155717518509271.xml · derivative · entry 3 Biondi Paul · CIK 0001744508 · SVP, Head of Strategy & BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,776 Underlying: Common Stock, $0.10 par value · 592 shares Expires 2021-10-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit coverts into one share of common stock upon vesting. F1 · derivative.exercise_date: Represents vesting of one quarter of restricted stock units granted on October 2, 2017. The balance of the award is scheduled to vest in three equal installments on the second, third and fourth anniversaries of the grant date. F1 · derivative.expiration_date: Represents vesting of one quarter of restricted stock units granted on October 2, 2017. The balance of the award is scheduled to vest in three equal installments on the second, third and fourth anniversaries of the grant date. Read SEC document |
| October 02, 2018 Filed May 6, 2019 20:39 UTC Amendment | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 292 | $62.80 | $18,337.60 |
DisclosureSEC source: 0000014272-19-000110 · wf-form4a_155717518509271.xml · nonDerivative · entry 2 Biondi Paul · CIK 0001744508 · SVP, Head of Strategy & BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,041 F3 · shares: Shares withheld for payment of taxes upon vesting of awards. F2 · balance_after: Due to an administrative error, this Form 4 is being amended to report in Column 5 the correct number of securities beneficially owned following the reported transaction. Read SEC document |
| October 02, 2018 Filed May 6, 2019 20:39 UTC Amendment | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionCommon Stock, $0.10 par value | 592 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-19-000110 · wf-form4a_155717518509271.xml · nonDerivative · entry 1 Biondi Paul · CIK 0001744508 · SVP, Head of Strategy & BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,333 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents vesting of one quarter of restricted stock units granted on October 2, 2017. The balance of the award is scheduled to vest in three equal installments on the second, third and fourth anniversaries of the grant date. F2 · balance_after: Due to an administrative error, this Form 4 is being amended to report in Column 5 the correct number of securities beneficially owned following the reported transaction. Read SEC document |
| July 01, 2018 Filed Jul 4, 2018 01:24 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionRestricted Stock Units · Derivative | 1,461 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-18-000144 · wf-form4_153066747498817.xml · derivative · entry 3 Biondi Paul · CIK 0001744508 · SVP, Head of Strategy & BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 1,461 shares Expires 2018-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting. F3 · derivative.exercise_date: Represents final vesting of restricted stock units granted on July 1, 2013. F3 · derivative.expiration_date: Represents final vesting of restricted stock units granted on July 1, 2013. Read SEC document |
| July 01, 2018 Filed Jul 4, 2018 01:24 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 720 | $55.34 | $39,844.80 |
DisclosureSEC source: 0000014272-18-000144 · wf-form4_153066747498817.xml · nonDerivative · entry 2 Biondi Paul · CIK 0001744508 · SVP, Head of Strategy & BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 741 F1 · shares: Shares withheld for payment of taxes upon vesting of awards. Read SEC document |
| July 01, 2018 Filed Jul 4, 2018 01:24 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionCommon Stock, $0.10 par value | 1,461 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-18-000144 · wf-form4_153066747498817.xml · nonDerivative · entry 1 Biondi Paul · CIK 0001744508 · SVP, Head of Strategy & BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,461 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.